Yafang Ma
79# Qingchun Road
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Heat stress targets and degrades BCR::ABL1 oncoproteins to overcome drug-resistance in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Journal: Leukemia
Published: March 15, 2025
Carrageenan in meat: improvement in lipid metabolism due to Sirtuin1-mediated fatty acid oxidation and inhibited lipid bioavailability.
Journal: Food & function
Published: May 23, 2023
The landscape of novel strategies for acute myeloid leukemia treatment: Therapeutic trends, challenges, and future directions.
Journal: Toxicology and applied pharmacology
Published: April 11, 2023
Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia.
Journal: Frontiers in oncology
Published: August 21, 2020
PML-RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy-free postremission approach: A multiple institution experience.
Journal: Hematological oncology
Published: April 20, 2020
Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy.
Journal: Hematological oncology
Published: February 27, 2018
Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia.
Journal: Annals of hematology
Published: March 14, 2017
Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Journal: Frontiers of medicine
Published: July 27, 2016
All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis.
Journal: PloS one
Published: April 05, 2016
Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
Journal: Annals of hematology
Published: April 30, 2015
Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy.
Journal: Leukemia research
Published: February 20, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026